Clinical Trial Update: Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating postoperative concurrent chemoradiotherapy for high-risk salivary gland carcinomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Salivary Gland Carcinoma

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Salivary Gland Tumors, Head and Neck Cancer | Phase 2 | Status: COMPLETED